Etrinabdione (EHP-101; VCE-004.8) is a specific PPARγ and CB2 receptor dual agonist. Etrinabdione inhibits prolyl-hydroxylases (PHDs) and activates the HIF pathway. Etrinabdione, a semi-synthetic multitarget cannabinoquinoid, has potent anti-inflammatory activity. Etrinabdione attenuates adipogenesis and prevents diet-induced obesity .
Specifictaions: Moligand™, ≥98%
MDL Number: C28H35NO3
Molecular Formula: 433.58
PubChem CID: 118465221
Isomeric SMILES: CCCCCC1=C(C(=C(C(=O)C1=O)[C@@H]2C=C(CC[C@H]2C(=C)C)C)O)NCC3=CC=CC=C3
- UPC:
- 41105903
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- E650944-50mg
- CAS:
- 1818428-24-8
- Product Size:
- 50mg
akash.verma@cenmed.com
(732) 447-1115





